Top

Published in:

01-05-2005

Localization of Matrix Metalloproteinases, (MMPs) Their Tissue Inhibitors, and Vascular Endothelial Growth Factor (VEGF) in Growth Plates of Children and Adolescents Indicates a Role for MMPs in Human Postnatal Growth and Skeletal Maturation

Authors: G. Haeusler, I. Walter, M. Helmreich, M. Egerbacher

Published in: Calcified Tissue International | Issue 5/2005

Abstract

Numerous studies have focused on the expression, regulation, and biological significance of matrix metalloproteinases (MMPs) in the growth plate. Findings in mouse knockout models and in vitro data from various species indicate that MMPs not only degrade extracellular matrix components but may regulate the activity of local growth factors. In this study we investigated the presence, distribution, and activity of various MMPs and inhibitors, tissue transglutaminase (tTG or TG2) and vascular endothelial growth factor (VEGF) in the human child and adolescent growth plates by means of immunohistochemistry and gelatin zymography. Tissue was derived during orthopedic surgery (epiphysiodesis) in two prepubertal and four pubertal patients.

MMP-2 and MMP-14 were present in reserve cell chondrocytes. MMP-14 was the most prominent MMP within all zones of the growth plate including proliferating chondrocytes. MMP-1 and MMP-13 (collagenases 1 and 3), MMP-9 (gelatinases B), MMP-10, and MMP-11 (stromelysins) and VEGF were positive in hypertrophic chondrocytes and osteoblasts. MMP-2 showed the same expression pattern but was negative in osteoblasts. Osteoclasts stained positive for MMP-9, MMP-2, and TG2. Tissue inhibitor of MMP (TIMP)-1 was present in all zones of the growth plate, osteoblasts, and osteoclasts; TIMP-2 was found in hypertrophic chondrocytes and osteoblasts. In summary, the presence of MMPs, TIMPs, TG2, and VEGF in our study indicated that the MMPs are relevant in growth plate physiology during the postnatal period in humans. The specific location of MMP expression within the growth plate may be the basis for further studies on the role of MMPs in the local regulation of chondrocyte differentiation, proliferation, and ossification at the chondroosseus junction.

Ballock, RT, O’Keefe, RJ 2003The biology of the growth plateJ Bone Joint Surg85715726PubMedCrossRef

Birkedahl-Hansen, H, Moore, WG, Bodden, MK, Windsor, LJ, Birkedahl-Hansen, B, Carlo, A, Engler, JA 1993Matrix metalloproteinases: a reviewCrit Rev Oral Biol Med4197250CrossRef

Birkedahl-Hansen, H 1995Proteolytic remodelling of extracellular matrixCurr Opin Cell Biol72835

Visse, R, Nagase, H 2003Matrix metalloproteinases and tissue inhibitors of metalloproteinasesCirc Res92827839PubMedCrossRef

Vu, TH, Werb, Z 2000Matrix metalloproteinase: effectors of development and normal physiologyGenes Dev1421232133PubMedCrossRef

Ortega, N, Behonick, D, Stickens, D, Werb, Z 2003How proteinases regulate bone morphogenesisAnn N Y Acad Sci995109116PubMedCrossRef

Stamenkovic, I 2003Extracellular matrix remodelling: the role of matrix metalloproteinasesJ Pathol200448464PubMedCrossRef

Somerville, RP, Oblander, SA, Apte, SS 2003Matrix metalloproteinases: old dogs with new tricksGenome Biol42161–11PubMedPubMedCentralCrossRef

Gomez, DE, Alonso, DF, Yoshiji, H, Thorgeirsson, UP 1997Tissue inhibitors of metalloproteinases: structure, regulation and biological functionsEur J Cell Biol74111122PubMed

10.

Bord, S, Horner, A, Beeton, CA, Hembry, RM, Compston, JE 1999Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human boneBone24229235PubMedCrossRef

11.

Greenberg, CS, Birckbichler, PJ, Rice, RH 1991Transglutaminases: multifunctional cross-linking enzymes that stabilize tissuesFASEB J530713077PubMedCrossRef

12.

Aeschlimann, D, Wetterwald, A, Fleisch, H, Paulsson, M 1993Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytesJ Cell Biol12014611470PubMedCrossRef

13.

Nurminskaya, M, Magee, C, Faverman, L, Linsenmayer, TF 2003Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periostal boneDev Biol263139152PubMedCrossRef

14.

Johansson, N, Saarialho-Kere, U, Airola, K, Herva, R, Nissinen, L, Westermarck, J, Vuorio, E, Heino, J, Kähäri, VM 1997Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periostal cells and osteoblasts during human fetal bone developmentDev Dyn208387397PubMedCrossRef

15.

Stahle-Bäckdahl, MS, Sandstedt, B, Bruce, K, Lindahl, A, Jimenez, MG, Vega, JA, Lopez-Otin, C 1997Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodelling and in rheumatoid arthritisLab Invest76717728PubMed

16.

Bord, S, Horner, A, Hembry, RM, Compston, JE 1998Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal developmentBone23712PubMedCrossRef

17.

Vu, TH, Shipley, JM, Bergers, G, Berger, JE, Helms, JA, Hanahan, D, Shapiro, SD, Senior, RM, Werb, Z 1998MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytesCell93411422PubMedPubMedCentralCrossRef

18.

Holmbeck, K, Bianco, P, Caterina, J, Yamada, S, Kromer, M, Kuznetsov, SA, Mankani, M, Robey, PG, Poole, AR, Pidoux, I, Ward, JM, Birkedahl-Hansen, H 1998MT-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnoverCell998192CrossRef

19.

Engsig, MT, Chen, QJ, Vu, TH, Pedersen, AC, Therkidsen, B, Lund, LR, Henriksen, K, Lenhard, T, Foged, NT, Werb, Z, Delaisse, JM 2000Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bonesJ Cell Biol151879889PubMedPubMedCentralCrossRef

20.

Balbin, M, Fueyo, A, Knauper, V, Lopez, JM, Alvarez, J, Sanchez, LM, Quesada, V, Bordallo, J, Murphy, G, Lopez-Otin, C 2001Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantationJ Biol Chem2761025310262PubMedCrossRef

21.

Billinghurst, RC, Dahlberg, L, Ionescu, M, Reiner, A, Bourne, R, Rorabeck, C, Mitchell, P, Hambor, J, Diekmann, O, Tschesche, H, Chen, J, Wart, H, Poole, AR 1997Enhanced cleavage of type II collagen by collagenases in osteoarthritic cartilageJ Clin Invest9915341543PubMedPubMedCentralCrossRef

22.

Wu, CW, Tchetina, EV, Mwale, F, Hasty, K, Pidoux, I, Reiner, A, Chen, J, Wart, HE, Poole, AR 2002Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralizationJ Bone Mineral Res17639651CrossRef

23.

Mwale, F, Tchetina, E, Wu, CW, Poole, AR 2002The assembly and remodeling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: An in situ study of collagens II and IX and proteoglycanJ Bone Miner Res17275283PubMedCrossRef

24.

Wu, W, Mwale, F, Tchetina, E, Kojima, T, Yasuda, T, Poole, R 2001Cartilage matrix resorption in skeletogenesisNovartis Found Symp232158166PubMed

25.

Gack, S, Vallon, R, Schmidt, J, Grigoriadis, A, Tuckermann, J, Schenkel, J, Weiher, H, Wagner, EF, Angel, P 1995Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytesCell Growth Differ6759767PubMed

26.

Freije, JM, Diez-Itza, I, Balbin, M, Sanchez, LM, Blasco, R, Tolivia, J, Lopez-Otin, C 1994Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomasJ Biol Chem2691676616773PubMedCrossRef

27.

Fowlkes, JL, Enghild, JJ, Suzuki, K, Nagase, H 1994Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast culturesJ Biol Chem2692574225746PubMedCrossRef

28.

Sato, T, Foget, NT, Delaisse, JM 1998The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitorsJ Bone Miner Res135966PubMedCrossRef

29.

Delaisse, JM, Eeckhout, Y, Neff, L, Francois-Gillet, C, Henriet, P, Su, Y, Vaes, G, Baron, R 1993(Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartmentJ Cell Sci10610711082PubMedCrossRef

30.

Hill, PA, Murphy, G, Docherty, AJP, Hembry, RM, Millican, A, Reynolds, JJ, Meikle, MC 1994The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclastsJ Cell Sci10730553064PubMedCrossRef

31.

Bord, S, Horner, A, Hembry, RM, Reynolds, JJ, Compston, JE 1997Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic boneJ Anat1913948PubMedPubMedCentralCrossRef

32.

Chambers, TJ, Darby, JA, Fuller, K 1985Mammalian collagenase predisposes bone surfaces to osteoclastic resorptionCell Tissue Res241671675PubMedCrossRef

33.

Sato, H, Kinoshita, T, Takino, T, Nakayama, K, Seiki, M 1996Activation of a recombinant membrane type 1-matalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2FEBS Lett393101104PubMedCrossRef

34.

Kinoh, H, Sato, H, Tsunezuka, Y, Takino, T, Kawashima, A, Okada, Y, Seiki, M 1996MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A) is expressed with its substrate in mouse tissue during embryogenesisJ Cell Sci109953959PubMedCrossRef

35.

Apte, SS, Fukai, N, Beier, DR, Olsen, BR 1997The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesisJ Biol Chem2722551125517PubMedCrossRef

36.

Gerber, HP, Vu, TH, Ryan, AM, Kowalski, J, Werb, Z, Ferrara, N 1996VEGF couples hypertrophic cartilage remodelling, ossification and angiogenesis during enchondral bone formationNature Med6623628

37.

Carlevaro, MF, Cermelli, S, Cancedda, R, Cancedda, F 2000Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during enchondral bone formationJ Cell Sci1135969PubMedCrossRef

38.

Belotti, D, Paganoni, P, Manenti, L, Garofalo, A, Marchini, S, Taraboletti, G, Giavazzi, R 2003Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formationCancer Res6352245229PubMed

39.

Horner, A, Bishop, NJ, Bord, S, Beeton, C, Kelsall, AW, Coleman, N, Compston, JE 1999Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilageJ Anat194519524PubMedPubMedCentralCrossRef

40.

Petersen, W, Tsokos, M, Pufe, T 2002Expression of VEGF 121 and VEGF 165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilageJ Anat201153157PubMedPubMedCentralCrossRef

41.

Lin, R, Amizuka, N, Sasaki, T, Aarts, MM, Ozawa, H, Goltzman, D, Henderson, JE, White, JH 20021-Alpha, 25-dihydroxyvitamin D3 promotes vascularization of chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9J Bone Miner Res1716041612PubMedCrossRef

42.

Kawashima-Ohya, Y, Satakeda, H, Kuruta, Y, Kawamoto, T, Yan, W, Akagawa, Y, Hayakawa, T, Noshiro, M, Okada, Y, Nakamura, S, Kato, Y 1998Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte culturesEndocrinology13921202127PubMedCrossRef

43.

Sirum, KL, Brinckerhoff, CE 1989Cloning of the genes for human stromelysin and stromelysin-2: differential expression in rheumatoid synovial fibroblastsBiochemistry2886918698PubMedCrossRef

44.

Fernandes, JC, Martel-Pelletier, J, Pelletier, JP 2002The role of cytokines in osteoarthritis pathophysiologyBiorheology39237246PubMed

45.

Brown, CC, Hembry, RM, Reynolds, JJ 1989Immunolocalization of metalloproteinases and their inhibitors in the rabbit growth plateJ Bone Joint Surg Am71580593PubMedCrossRef

46.

Armstrong, AL, Barrach, HJ, Ehrlich, MG 2002Identification of the metalloproteinase stromelysin in the physisJ Orthop Res20289294PubMedCrossRef

47.

Stamenkovic, I 2000Matrix metalloproteinases in tumor invasion and metastasisCancer Biol10415433CrossRef

48.

Joronen, K, Salminen, H, Glumoff, V, Savontaus, M, Vuorio, E 2000Temporospatial expression of tissue inhibitors of matrix metalloproteinases-1, -2, and -3 during development, growth and aging of the mouse skeletonHistochem Cell Biol114157165PubMedCrossRef

49.

Geoffrey, V, Marty-Morieux, C, Le Goupil, N, Clement-Lacroix, P, Terraz, C, Frain, M, Roux, S, Rossert, J, Vernejoul, MC 2004In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone massJ Bone Miner Res19811822CrossRef

50.

Sobue, T, Hakeda, Y, Kobayashi, Y, Hayakawa, H, Yamashita, K, Aoki, T, Kumegawa, M, Noguchi, T, Hayakawa, T 2001Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclastsJ Bone Miner Res1622052214PubMedCrossRef

51.

Johnson, KA, Etten, D, Nanda, N, Graham, RM, Terkeltaub, RA 2003Distinct transglutaminase 2-independent and transglutaminase-dependent pathways mediate articular chondrocyte hypertrophyJ Biol Chem211882418832CrossRef

52.

Nanda, N, Iismaa, SE, Owens, WA, Huasain, A, Mackay Graham, F RM 2001Targeted inactivation of Gh/tissue transglutaminase IIJ Biol Chem2762067320678PubMedCrossRef

53.

Uchide, K, Ueno, H, Takizawa, N, Okada, Y 2003Reduced levels of MMP-2 and TIMP-1 in dyssegmental dysplasiaJ Bone Miner Res18381382PubMedCrossRef

Title: Localization of Matrix Metalloproteinases, (MMPs) Their Tissue Inhibitors, and Vascular Endothelial Growth Factor (VEGF) in Growth Plates of Children and Adolescents Indicates a Role for MMPs in Human Postnatal Growth and Skeletal Maturation
Authors: G. Haeusler
I. Walter
M. Helmreich
M. Egerbacher
Publication date: 01-05-2005
Publisher: Springer New York
Published in: Calcified Tissue International / Issue 5/2005
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-004-0161-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2005

Expression of PPARγ and β/δ in Human Primary Osteoblastic Cells: Influence of Polyunsaturated Fatty Acids

Analysis of Bone Mineral Content in Horizontally HIV-Infected Children Naïve to Antiretroviral Treatment

Measurement of Estrogen Effect on Bone Turnover by 2H2O Labeling

Towards Standardization of Dual X-ray Absorptiometry (DXA) at the Forearm

Depressed Bone Mineralization Following High Dose TGF-β1 Application in an Orthopedic Implant Model

Quantification of Trabecular Bone Structure Using Magnetic Resonance Imaging at 3 Tesla—Calibration Studies Using Microcomputed Tomography as a Standard of Reference

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials